Enliven Therapeutics, Inc. (ELVN) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 14K | 46K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 24K | 25K |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -14K | -46K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -24K | -25K |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | 100% | 100% | - | - | - |
| Operating Expenses | 27.82M | 34.24M | 25.1M | 28.58M | 31.69M | 26.9M | 27.07M | 24.6M | 25.99M | 22.73M | 24.25M | 20.13M | 16.42M | 10.16M | 10.93M | 9.02M | 8.68M | 8.39M | 13.63M | 13.14M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 7.14M | 13.04M | 6.87M | 7.09M | 6.8M | 6.17M | 5.81M | 5.78M | 6.02M | 4.82M | 3.34M | 3.65M | 4.54M | 1.97M | 3.1M | 1.08M | 1.62M | 1.53M | 3.24M | 3.07M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 20.69M | 21.25M | 18.23M | 21.49M | 24.89M | 20.72M | 21.26M | 18.83M | 19.97M | 17.91M | 19.61M | 15.18M | 11.88M | 8.2M | 7.83M | 7.94M | 7.06M | 6.86M | 10.4M | 10.07M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1000K | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -27.82M | -34.28M | -25.1M | -28.58M | -31.69M | -26.9M | -27.07M | -24.6M | -25.99M | -22.73M | -24.25M | -20.13M | -16.42M | -10.16M | -10.93M | -9.02M | -8.68M | -8.39M | -13.66M | -13.17M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 12.21% | -27.47% | 7.29% | -16.18% | -21.96% | -18.33% | -11.63% | -22.2% | -58.28% | -123.64% | -121.77% | -123.31% | -89.19% | -21.06% | 19.95% | 31.54% | 15.58% | 27.32% | -9.32% | -27.83% |
| EBITDA | -27.81M | -34.24M | -25.03M | -28.5M | -31.62M | -26.82M | -26.99M | -24.52M | -25.91M | -22.65M | -24.17M | -20.06M | -16.35M | -10.1M | -10.87M | -8.96M | -8.64M | -8.36M | -13.63M | -13.14M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 12.05% | -27.68% | 7.24% | -16.22% | -22.04% | -18.39% | -11.66% | -22.26% | -58.45% | -124.29% | -122.27% | -123.78% | -89.27% | -20.77% | 20.25% | 31.8% | 15.76% | 27.46% | -9.35% | -27.9% |
| D&A (Non-Cash Add-back) | 14K | 46K | 62K | 81K | 74K | 80K | 80K | 78K | 79K | 78K | 78K | 74K | 67K | 64K | 60K | 52K | 39K | 33K | 24K | 25K |
| EBIT | -27.82M | -34.28M | -20.15M | -28.58M | -31.69M | -26.9M | -27.07M | -24.6M | -25.99M | -22.73M | -24.25M | -20.13M | -16.42M | -10.16M | -10.93M | -9.02M | -8.68M | -8.39M | -13.65M | -13.16M |
| Net Interest Income | 4.2M | 4.62M | 4.95M | 3.25M | 3.2M | 3.72M | 3.84M | 4.09M | 3.25M | 3.37M | 3.49M | 3.41M | 1.69M | 613K | 380K | 127K | 9K | 3K | 30K | 48K |
| Interest Income | 4.2M | 4.62M | 4.95M | 3.25M | 3.2M | 3.72M | 3.84M | 4.09M | 3.25M | 3.37M | 3.49M | 3.41M | 1.69M | 613K | 380K | 127K | 9K | 3K | 30K | 48K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 4.2M | 4.62M | 4.95M | 3.25M | 3.15M | 3.72M | 3.91M | 4.88M | 3.25M | 3.36M | 3.48M | 3.41M | 1.69M | 613K | 380K | 127K | 9K | 3K | 12K | 8K |
| Pretax Income | -23.63M | -29.67M | -20.15M | -25.34M | -28.54M | -23.18M | -23.16M | -19.72M | -22.74M | -19.37M | -20.77M | -16.72M | -14.72M | -9.55M | -10.55M | -8.89M | -8.67M | -8.39M | -13.65M | -13.16M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 232K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -1.18% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -23.63M | -29.67M | -20.15M | -25.34M | -28.54M | -23.18M | -23.16M | -19.95M | -22.74M | -19.37M | -20.77M | -16.72M | -14.72M | -9.55M | -10.55M | -8.89M | -8.67M | -8.39M | -13.65M | -13.16M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 17.23% | -27.99% | 12.99% | -26.99% | -25.53% | -19.67% | -11.49% | -19.31% | -54.43% | -102.83% | -96.79% | -88.11% | -69.85% | -13.8% | 22.66% | 32.46% | 15.48% | 27.14% | -9.85% | -28.98% |
| Net Income (Continuing) | -23.63M | -29.67M | -20.15M | -25.34M | -28.54M | -23.18M | -23.16M | -19.95M | -22.74M | -19.37M | -20.77M | -16.72M | -14.72M | -9.55M | -10.55M | -8.89M | -8.67M | -8.39M | -13.65M | -13.16M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.38 | -0.45 | -0.32 | -0.49 | -0.57 | -0.46 | -0.48 | -0.41 | -0.54 | -0.47 | -0.51 | -0.41 | -0.80 | 4.90 | -0.70 | -1.74 | -2.23 | -2.18 | -2.19 | -2.97 |
| EPS Growth % | 33.33% | 2.17% | 33.33% | -19.51% | -5.56% | 2.13% | 5.88% | 0% | 32.5% | -109.59% | 27.14% | 76.44% | 64.13% | 324.77% | 68.04% | 41.41% | 4.29% | 17.11% | 23.43% | -25.32% |
| EPS (Basic) | -0.38 | -0.45 | -0.32 | -0.49 | -0.57 | -0.46 | -0.48 | -0.41 | -0.54 | -0.47 | -0.51 | -0.41 | -0.80 | 4.90 | -0.70 | -1.74 | -2.23 | -2.18 | -2.19 | -2.97 |
| Diluted Shares Outstanding | 62.8M | 56.66M | 62.09M | 52.11M | 50.05M | 49.86M | 48.27M | 48.08M | 42.05M | 41.13M | 41.03M | 40.96M | 18.52M | 6.57M | 6.57M | 6.57M | 6.57M | 6.57M | 6.22M | 4.43M |
| Basic Shares Outstanding | 62.8M | 56.66M | 62.09M | 52.11M | 50.05M | 49.86M | 48.27M | 48.08M | 42.05M | 41.13M | 41.03M | 40.96M | 18.52M | 6.57M | 6.57M | 6.57M | 6.57M | 6.57M | 6.22M | 4.43M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |